JINLING PHARM.
0009196.291.62% ( +0.10 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: JINLING PHARM.(000919) the Revenue is 768.67 M (-5.1%);the EBIT is 20.09 M (+9.7%);the EPS is 0.045 (+21.62%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.77B5.10%
----
----
EBIT
0.02B9.70%
----
----
EPS
0.04521.62%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf